念珠菌病和各种酵母菌病

M. Develoux (Maître de conférences, praticien hospitalier) , S. Bretagne (Professeur des Universités, praticien hospitalier)
{"title":"念珠菌病和各种酵母菌病","authors":"M. Develoux (Maître de conférences, praticien hospitalier) ,&nbsp;S. Bretagne (Professeur des Universités, praticien hospitalier)","doi":"10.1016/j.emcmi.2005.04.001","DOIUrl":null,"url":null,"abstract":"<div><p>The spectrum of <em>Candida</em> and other yeast infections is wide, from skin or nail infections to disseminated candidiasis. The yeasts involved in human pathology are few, compared with the whole fungal kingdom. These yeasts have different biologic patterns but share the feature to be mainly opportunistic agents: their pathogenic power is only expressed when risk factors are present. Among them, <em>Candida albicans</em> remains the most frequent although non albicans species are more and more reported, especially in disseminated infections. The diagnosis relies on the microbiological analysis of clinical samples but the interpretation of a positive culture should be part of an overall analysis that integrates clinical symptoms and risk factors. Indeed, <em>C. albicans</em> lives as a benign commensal on digestive and vaginal mucosa; its presence does not necessarily indicate a disease. Treatment of localized yeast infections is based on the suppression of risk factors and the use of topic antifungal agents. In case of well-documented reoccurrences, systemic antifungal drugs may be proposed. For disseminated infections, a systemic antifungal agent is mandatory; in such cases, the associated mortality remains high, close to 50%, despite the recent development of new antifungal molecules.</p></div>","PeriodicalId":100430,"journal":{"name":"EMC - Maladies Infectieuses","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcmi.2005.04.001","citationCount":"45","resultStr":"{\"title\":\"Candidoses et levuroses diverses\",\"authors\":\"M. Develoux (Maître de conférences, praticien hospitalier) ,&nbsp;S. Bretagne (Professeur des Universités, praticien hospitalier)\",\"doi\":\"10.1016/j.emcmi.2005.04.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The spectrum of <em>Candida</em> and other yeast infections is wide, from skin or nail infections to disseminated candidiasis. The yeasts involved in human pathology are few, compared with the whole fungal kingdom. These yeasts have different biologic patterns but share the feature to be mainly opportunistic agents: their pathogenic power is only expressed when risk factors are present. Among them, <em>Candida albicans</em> remains the most frequent although non albicans species are more and more reported, especially in disseminated infections. The diagnosis relies on the microbiological analysis of clinical samples but the interpretation of a positive culture should be part of an overall analysis that integrates clinical symptoms and risk factors. Indeed, <em>C. albicans</em> lives as a benign commensal on digestive and vaginal mucosa; its presence does not necessarily indicate a disease. Treatment of localized yeast infections is based on the suppression of risk factors and the use of topic antifungal agents. In case of well-documented reoccurrences, systemic antifungal drugs may be proposed. For disseminated infections, a systemic antifungal agent is mandatory; in such cases, the associated mortality remains high, close to 50%, despite the recent development of new antifungal molecules.</p></div>\",\"PeriodicalId\":100430,\"journal\":{\"name\":\"EMC - Maladies Infectieuses\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.emcmi.2005.04.001\",\"citationCount\":\"45\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMC - Maladies Infectieuses\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1638623X05000053\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Maladies Infectieuses","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1638623X05000053","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 45

摘要

念珠菌和其他酵母感染的范围很广,从皮肤或指甲感染到播散性念珠菌感染。与整个真菌王国相比,参与人类病理学的酵母很少。这些酵母具有不同的生物学模式,但有一个共同的特点,即主要是机会性病原体:它们的致病力只有在存在危险因素时才会表现出来。其中,白色念珠菌仍然是最常见的,尽管非白色念珠菌的报道越来越多,尤其是在播散性感染中。诊断依赖于临床样本的微生物分析,但对阳性培养物的解释应该是综合临床症状和风险因素的整体分析的一部分。事实上,白色念珠菌是消化道和阴道粘膜上的良性共生菌;它的存在并不一定意味着疾病。局部酵母感染的治疗是基于抑制危险因素和使用主题抗真菌药物。在有充分证据证明复发的情况下,可以建议使用全身抗真菌药物。对于播散性感染,必须使用系统性抗真菌药物;在这种情况下,尽管最近开发了新的抗真菌分子,但相关的死亡率仍然很高,接近50%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Candidoses et levuroses diverses

The spectrum of Candida and other yeast infections is wide, from skin or nail infections to disseminated candidiasis. The yeasts involved in human pathology are few, compared with the whole fungal kingdom. These yeasts have different biologic patterns but share the feature to be mainly opportunistic agents: their pathogenic power is only expressed when risk factors are present. Among them, Candida albicans remains the most frequent although non albicans species are more and more reported, especially in disseminated infections. The diagnosis relies on the microbiological analysis of clinical samples but the interpretation of a positive culture should be part of an overall analysis that integrates clinical symptoms and risk factors. Indeed, C. albicans lives as a benign commensal on digestive and vaginal mucosa; its presence does not necessarily indicate a disease. Treatment of localized yeast infections is based on the suppression of risk factors and the use of topic antifungal agents. In case of well-documented reoccurrences, systemic antifungal drugs may be proposed. For disseminated infections, a systemic antifungal agent is mandatory; in such cases, the associated mortality remains high, close to 50%, despite the recent development of new antifungal molecules.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Virus de l'immunodéficience humaine Bactéries hautement résistantes aux antibiotiques émergentes et leur prévention Borréliose de Lyme Infections à Pseudomonas aeruginosa Coqueluche : physiopathologie, diagnostic et prévention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1